A drug with the SMILES Brc1ccc2c(c1)C(c1ccc(N3CCOCC3)cc1)=NNC(c1cccs1)=N2 has a human ether-à-go-go related gene (hERG) inhibition at 10uM of 4.369%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_10uM__names__noun} of {herg_central_at_10uM#}{herg_central_at_10uM__units}.
Brc1ccc2c(c1)C(c1ccc(N3CCOCC3)cc1)=NNC(c1cccs1)=N2
Brc1ccc2c(c1)C(c1ccc(N3CCOCC3)cc1)=NNC(c1cccs1)=N2
4-[4-(7-bromo-2-thiophen-2-yl-3H-1,3,4-benzotriazepin-5-yl)phenyl]morpholine